Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 7.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 17.50
  • 52 Week Low: 6.75
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 214,789
  • Market Cap: £13.77m
  • RiskGrade: 348
  • Beta: 0.04

Latest ShareCast News

Renalytix enters new collaboration with NYKHM

By Josh White

Date: Tuesday 03 Jun 2025

(Sharecast News) - Renalytix announced a new collaboration with New York Kidney & Hypertension Medicine (NYKHM) on Tuesday, aimed at expanding access to its FDA-approved kidneyintelX.dkd test across underserved communities in the Greater New York area.

Renalytix Q3 revenues up 20pc

By Iain Gilbert

Date: Thursday 10 Apr 2025

(Sharecast News) - Precision medicine business Renalytix said on Thursday that Q3 trading was in line with expectations, delivering 20% quarter-on-quarter revenue growth as it reached "the key milestone" of processing over 1,000 billable tests within the quarter for the first time.

Renalytix terminates formal sale process

By Josh White

Date: Tuesday 20 Aug 2024

(Sharecast News) - Renalytix, a company specialising in artificial intelligence-enabled diagnostics for kidney disease, announced the termination of its formal sale process on Tuesday.

Renalytix test gets US Medicare coverage determi... 14-Jun-2024 ShareCast
Renalytix surges on takeover approach 04-Mar-2024 ShareCast
Renalytix shares jump on draft US Medicare cover... 09-Feb-2024 ShareCast
Renalytix kidney test claims allowed by US Paten... 06-Oct-2023 ShareCast
Renalytix gets KidneyIntelX included in major cl... 21-Aug-2023 ShareCast
Renalytix launches kidney disease test in Arabia... 21-Jul-2023 ShareCast
Renalytix test gets US FDA marketing authorisation 30-Jun-2023 ShareCast
Renalytix secures expanded coverage in Washingto... 22-May-2023 ShareCast
Renalytix reports positive study on clinical val... 19-Apr-2023 ShareCast
Renalytix rises on publication of positive evide... 29-Nov-2022 ShareCast
Renalytix reports positive outcomes from Mount S... 10-Jun-2022 ShareCast
Renalytix completes financing to support its gro... 08-Apr-2022 ShareCast
Revenue rises, losses widen in first half at Ren... 31-Mar-2022 ShareCast
Renalytix hits patient milestone for kidney and ... 29-Mar-2022 ShareCast
Renalytix launches new US provider access portal 09-Mar-2022 ShareCast
Renalytix presents new clinical data on KidneyIn... 24-Feb-2022 ShareCast
Renalytix inks partnership with Singing River He... 10-Jan-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 7.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 17.50
52 Week Low 6.75
Volume 214,789
Shares Issued 189.93m
Market Cap £13.77m
Beta 0.04
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.66% above the market average18.66% above the market average18.66% above the market average18.66% above the market average18.66% above the market average
51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average
Price Trend
88.53% below the market average88.53% below the market average88.53% below the market average88.53% below the market average88.53% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth
28.83% below the market average28.83% below the market average28.83% below the market average28.83% below the market average28.83% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

RENX Dividends

No dividends found

Trades for 21-Jul-2025

Time Volume / Share Price
16:02 15,000 @ 7.50p
14:24 55,000 @ 7.50p
14:07 100,000 @ 7.28p
10:46 35,085 @ 7.10p
08:08 9,704 @ 7.10p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page